Mycobacterial Diseases

Mycobacterial Diseases
Open Access

ISSN: 2161-1068

+44 1478 350008

Research Article - (2011) Volume 1, Issue 2

Rv2820c of Beijing/W strains enhances Mycobacterium tuberculosis survival in human macrophages

J.T. Lam1, P.L. Ho1, X.H. Weng2, W.H. Zhang2, S. Chen2 and W.C. Yam1
1Department of Microbiology, The University of Hong Kong, University Pathology Building, Queen Mary Hospital Compound, Pukfulam Road, Hong Kong Special Administrative Region, China
2Department of Infectious Diseases, Huashan Hospital, Fudan University, 12 Wulumuqi Road, Shanghai, China

Abstract

The ability to survive in human macrophages is a hallmark of the virulence of Mycobacterium tuberculosis. Although the intracellular parasitism is apparent, the molecular determinants behind are still largely unknown. The truncated Rv2820c of the Beijing/W strains of Mycobacterium tuberculosis was previously shown to enhance the survival of Mycobacterium smegmatis in the human macrophages. The enhanced intracellular survival, however, was not observed in the recombinant harboring the intact Rv2820c of the non-Beijing/W strains. In the current investigation, the role of the truncated Rv2820c in M. tuberculosis was examined using a ‘gain-of-function’ manner. The truncated Rv2820c was transformed into non-Beijing/W strains of M. tuberculosis and the resulting recombinants were used to infect the monocytic cell line THP-1. The ex vivo infection showed that the non-Beijing/W M. tuberculosis recombinants survived significantly better than the vector controls after ten days of infection (P < 0.05; independent samples t-test, two-tailed). Similar levels of interleukin-6, interleukin-10, and tumor necrosis factor-alpha were secreted from the macrophages infected with those non-Beijing/W recombinants. This study showed that the Rv2820c of the Beijing/W strains is capable of enhancing the M. tuberculosis survival in the human macrophages, but is unlikely to evoke a different profile of cytokine secretion from the infected macrophages. It suggests that the truncated Rv2820c may be another Beijing/W-specific virulence determinant.

Keywords: Mycobacterium tuberculosis; Beijing/W strains; Rv2820c; THP-1 cells

Introduction

The phenotypic virulence of M. tuberculosis is not invariable among different strains. Particular strains of M. tuberculosis, such as the Beijing/W family, have proven to be more virulent using ex vivo [1,2] and in vivo models [3,4]. The Beijing/W family was shown to grow more rapidly inside human macrophages [1,2], induce a weaker cell mediated immunity [5] but a stronger humoral immunity [6], cause a higher and earlier mortality in mice [3,4,7], and increase the likelihood to cross blood brain barrier and cause disseminated infection in rabbits [8]. Unique virulent factors may be evolved and conserved among the descendants of the Beijing/W family.

The polyketide synthase-derived phenolic glycolipid (PGL) is one of these Beijing/W-specific virulence determinants [7]. The PGL is capable of suppressing the liberation of tumor necrosis factoralpha (TNF-α), interlekin (IL)-6, and IL-12 from macrophage dosedependently [7]. This PGL is commonly found in the Beijing/W strains but not in the non-Beijing/W strains, such as the H37Rv and the CDC1551 [7]. It is because a seven-base-pair frameshift deletion is present in the genome of the non-Beijing/W strains, which leads to the partition of the intact pks15/1 gene into two separated genes pks15 and pks1 [9]. The polyketide synthase encoded by the pks15/1 is essential for the production of PGL [9]. Inactivation of the pks15/1 not only compromises the production of PGL but also attenuates the hypervirulent phenotype of the Beijing/W strains in mice [7].

The truncated Rv2820c is possibly another Beijing/W-specific virulence determinant [10]. The truncated Rv2820c enhances the survival of Mycobacterium smegmatis recombinant in human macrophages and causes earlier death of zebrafish after infection with Mycobacterium marinum recombinant [10]. The truncation in the Rv2820c is caused by the Beijing/W-defining deletion RD207 [11]. This deletion is commonly found among the Beijing/W strains [10,12]. Non-Beijing/W strains possess an intact Rv2820c, which does not enhance the mycobacterial virulence ex vivo and in vivo [10]. Although the truncated Rv2820c was demonstrated to enhance the survival of the surrogate host M. smegmatis in human macrophages, the role of this protein in M. tuberculosis is uncertain.

In the current investigation, the role of the truncated Rv2820c in M. tuberculosis was examined using a ‘gain-of-function’ manner. The truncated Rv2820c was transformed into non-Beijing/W strains of M. tuberculosis, which possess the intact Rv2820c only. To determine whether the truncated Rv2820c enhances the M. tuberculosis survival in human macrophages, the survivability of the non-Beijing/W recombinants inside the human monocytic cell line THP-1 was measured. The secretion of IL-6, IL-10, and TNF-α from the infected macrophages was also quantified to determine whether the truncated Rv2820c is involved with immunomodulation.

Materials and Methods

Bacterial strains and growth conditions

Two non-Beijing/W strains of M. tuberculosis were used in this study. They were the laboratory strain H37Rv (ATCC 27294) and a clinical isolate H83 from our previous study [13]. The H37Rv was purchased from the American type culture collection (ATCC). The non- Beijing/W genotype of both strains was verified using the mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRUVNTR) as described previously [14]. These two M. tuberculosis strains were grown in Middlebrook 7H9 broth supplemented with 10% oleic acid albumin dextrose catalase (OADC), 0.2% glycerol, and 0.05% Tween-80 or on Middlebrook 7H10 plates supplemented with 10% OADC and 0.5% glycerol. The broth culture was grown at 37°C with shaking at 130 revolutions per minute (rpm) until mid-logarithmic phase. The agar plates were incubated at 37°C until visible colonies formed. Hygromycin was included at 50 μg/ml when growing the recombinants harboring the expression vector pVV16 (Tuberculosis Vaccine Testing and Research Materials, Colorado State University).

THP-1 cells

The human monocytic cell line THP-1 (ATCC TIB-202) was purchased from the ATCC. They were grown in RPMI 1640 supplemented with 10% fetal bovine serum (Gibco) at 37°C with 5% CO2. The THP-1 cells were induced with 20 nM phorbol ester 12-O-tetradecanoylphorbol-13-acetate (Sigma Aldrich) at a density of 3 x 105 cells in each well of a 24-well plate for 24 hours to differentiate into macrophage-like phagocytic cells [10].

Construction of recombinant M. tuberculosis strains

The truncated Rv2820c of the Beijing/W strains were amplified using the PfuTurbo Cx hotstart DNA polymerase (Stratagene) and the primers Rv2820c’-F (5’ TATAACATATGAACTCGCGGCTGTTTAGGTTCGAC) and Rv2820c’-R (5’ TATAAAAGCTTTCAGATCAGAGAGTCTCCGGACTCACC). The restriction sites incorporated in the amplicon were exposed using the restriction endonucleases NdeI and HindIII (New England BioLabs) and were ligated to the expression vector pVV16 using the T4 DNA ligase (New England BioLabs). Correct insertion was confirmed using nucleotide sequencing and the sequencing primers Seq-Fwd (5’ CGGTGAGTCGTAGGTCGGGACGG) and Seq-Rev (5’ TGCCTGGCAGTCGATCGTACGCTAG). A total of 1 μg of the resulting plasmid was electroporated into the M. tuberculosis strains H37Rv and the H83 at 2.5 kV, 1 kΩ, and 25 μF. A naked pVV16 was also transformed as a vector control.

ex vivo infection of THP-1 cells with M. tuberculosis recombinants

The differentiated THP-1 cells were infected with the midlogarithmic recombinants of M. tuberculosis at a multiplicity of infection (MOI) of 1 at 37°C with 5% CO2 for 24 hours. The mycobacterial suspension was passed through a 25-gauge needle (Terumo) ten times to disperse mycobacterial clumps prior to the inoculation [15]. The inoculum was enumerated using the plate counting method. To kill the extracellular mycobacteria, amikacin at 200 μg/ml was added to the cells and was incubated at 37°C with 5% CO2 for 1 hour. This was considered as the day 0 of infection. The cells were lyzed with 0.1% SDS after 0, 3, 6, and 10 days of infection. The intracellular mycobacteria were also enumerated using the plate counting method.

Measurement of cytokine secretion

The differentiated THP-1 cells were infected with the midlogarithmic recombinants of M. tuberculosis as described in the ‘ex vivo infection of THP-1 cells with M. tuberculosis recombinants’. The culture supernatant was collected at 4, 24, 48, and 96 hours after infection. A mock control without the addition of mycobacteria was also included in parallel. The levels of IL-6, IL-10, and TNF-α in the culture supernatant were quantified using the OptEIA human ELISA kit II (Becton Dickinson).

Statistical analysis

To detect any significant differences in the survivability of M. tuberculosis recombinants inside the THP-1 cells, an independent samples t-test (two-tailed) was performed using the PASW (formerly SPSS) Statistics 17.0 program (International Business Machines).

Results

Rv2820c of Beijing/W strains enhances M. tuberculosis survival in human macrophages

The truncated Rv2820c of the Beijing/W strains was transformed into the two non-Beijing/W strains of M. tuberculosis (the clinical isolate H83 and the laboratory strain H37Rv) and their recombinants were used to infect the THP-1 cells. The ex vivo infection showed that the survivability of both non-Beijing/W strains was enhanced after acquiring the truncated Rv2820c of the Beijing/W strains (Figure 1) and was significantly different with the vector controls after ten days of infection (PH37Rv = 0.036, PH83 = 0.047; independent samples t-test, two-tailed).

mycobacterial-diseases-Mycobacterium-tuberculosis

Figure 1: Survivability of Mycobacterium tuberculosis recombinants harboring truncated Rv2820c or vector alone inside THP-1 cells. The colony forming unit (CFU) of recombinants was normalized to the CFU on day 0. Mean percentage is shown while its error bars represents plus or minus standard error of the mean (±1 SEM) of three independent experiments performed in duplicate. * P < 0.05; independent samples t-test (two-tailed).

Rv2820c of Beijing/W strains did not induce a different cytokine secretion profile

The levels of IL-6, IL-10, and TNF-α secreted from the infected macrophages were quantified using the ELISA. The non-Beijing/W recombinants induced similar levels of IL-6, IL-10, and TNF-α from the infected macrophages (Figure 2). A different cytokine secretion profile was not observed for the non-Beijing/W strains after acquiring the truncated Rv2820c of the Beijing/W strains.

mycobacterial-diseases-tuberculosis-recombinants

Figure 2: Secretion of interleukin-6 (A), interleukin-10 (B), and tumor necrosis factor-alpha (C) from THP-1 cells infected with Mycobacterium tuberculosis recombinants harboring truncated Rv2820c or vector alone. Mean concentration is shown while its error bars represents plus or minus standard error of the mean (±1 SEM) of three independent experiments performed in duplicate.

Discussion

The deletion RD207 is an early event in the evolution of Beijing/W strains [12]. It causes not only the characteristic pattern of spacer oligotyping (spoligotyping), which loses the spacers from 1 to 34 [16], but also the 3’ truncation in the gene Rv2820c [11]. The truncated Rv2820c is capable of enhancing the survival of M. smegmatis in the human macrophages [10]. As the M. smegmatis is only a surrogate host, the results generated from this surrogate host may not be directly applicable to the M. tuberculosis. The current study examined the role of the truncated Rv2820c in M. tuberculosis using a ‘gain-of-function’ manner. The truncated Rv2820c was transformed into non-Beijing/W strains of M. tuberculosis, which possess the intact Rv2820c only. The intracellular survivability of non-Beijing/W recombinants, whether it was a clinical strain or a laboratory strain, was enhanced after acquiring the truncated Rv2820c. The current study confirmed the previous finding that the truncated Rv2820c of the Beijing/W strains enhances mycobacterial survival ex vivo [10].

A portion of the Beijing/W strains is capable of unbalancing the host immune response to a non-protective side [5,7,17]. They inhibit the production of pro-inflammatory cytokines, such as IL-6 and TNF-α [5,7], and simultaneously stimulate the production of antiinflammatory cytokines, such as IL-10 [17]. Both TNF-α and IL-6 are essential for the proper formation of granuloma [18]. The TNF-α is critical for the initiation of granuloma formation, whereas the IL-6 is important for the maintenance of granuloma [18]. The antiinflammatory cytokine IL-10 is originally used to calm the immune system down to avoid overreacting, but appears to be misused by the Beijing/W strains. To determine whether the truncated Rv2820c is involved with the immunomodulation, the levels of IL-6, IL-10, and TNF-α secreted from the infected macrophages were measured. A different cytokine secretion profile, however, was not observed in the macrophages infected with the non-Beijing/W recombinants.

In conclusion, the current study showed that the Rv2820c of Beijing/W strains is capable of enhancing the M. tuberculosis survival in the human macrophages, but is unlikely to evoke a different profile of cytokine secretion from the infected macrophages. It suggests that the truncated Rv2820c may be another Beijing/W-specific virulence determinant.

Acknowledgements

We would like to thank the Colorado State University for providing the expression vector pVV16 as part of NIH, NIAID Contract No. HHSN266200400091C, entitled ‘Tuberculosis Vaccine Testing and Research Materials’.

References

  1. Zhang M, Gong J, Yang Z, Samten B, Cave MD, et al. (1999) Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J Infect Dis 179: 1213-1217.
  2. Li Q, Whalen CC, Albert JM, Larkin R, Zukowski L, et al. (2002) Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model. Infect Immun 70: 6489-6493.
  3. Lopez B, Aguilar D, Orozco H, Burger M, Espitia C, et al. (2003) A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 133: 30-37.
  4. Dormans J, Burger M, Aguilar D, Hernandez-Pando R, Kremer K, et al. (2004) Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clin Exp Immunol 137: 460- 468.
  5. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, et al. (2001) Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha / beta. Proc Natl Acad Sci U S A 98: 5752-5757.
  6. Manca C, Reed MB, Freeman S, Mathema B, Kreiswirth B, et al. (2004) Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect Immun 72: 5511-5514.
  7. Reed MB, Domenech P, Manca C, Su H, Barczak AK, et al. (2004) A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431: 84-87.
  8. Tsenova L, Ellison E, Harbacheuski R, Moreira AL, Kurepina N, et al. (2005) Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J Infect Dis 192: 98-106.
  9. Constant P, Perez E, Malaga W, Laneelle MA, Saurel O, et al. (2002) Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J Biol Chem 277: 38148- 38158.
  10. Lam JT, Yuen KY, Ho PL, Weng XH, Zhang WH, et al. (2011) Truncated Rv2820c enhances mycobacterial virulence ex vivo and in vivo. Microb Pathog 50: 331-335.
  11. Tsolaki AG, Gagneux S, Pym AS, Goguet de la Salmoniere YO, Kreiswirth BN, et al. (2005) Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol 43: 3185-3191.
  12. Rindi L, Lari N, Cuccu B, Garzelli C (2009) Evolutionary pathway of the Beijing lineage of Mycobacterium tuberculosis based on genomic deletions and mutT genes polymorphisms. Infect Genet Evol 9: 48-53.
  13. Wong KC, Leong WM, Law HK, Ip KF, Lam JT, et al. (2007) Molecular characterization of clinical isolates of Mycobacterium tuberculosis and their association with phenotypic virulence in human macrophages. Clin Vaccine Immunol 14: 1279-1284.
  14. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, et al. (2006) Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 44: 4498-4510.
  15. Stokes RW, Norris-Jones R, Brooks DE, Beveridge TJ, Doxsee D, et al. (2004) The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages. Infect Immun 72: 5676-5686.
  16. van Soolingen D, Qian L, de Haas PE, Douglas JT, Traore H, et al. (1995) Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol 33: 3234-3238.
  17. Ordway D, Henao-Tamayo M, Harton M, Palanisamy G, Troudt J, et al. (2007) The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J Immunol 179: 522-531.
  18. Welsh KJ, Abbott AN, Hwang SA, Indrigo J, Armitige LY, et al. (2008) A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response. Microbiology 154: 1813-1824.
Citation: Lam JT, Ho PL, Weng XH, Zhang WH, Chen S, et al. (2011) Rv2820c of Beijing/W strains enhances Mycobacterium tuberculosis survival in human macrophages. Mycobact Diseases 1:104.

Copyright: © 2011 Lam JT, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top